2-bromo-2-(4-fluorophenyl)-1-(4-methoxyphenyl)ethan-1-one | 951744-04-0

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 2-bromo-2-(4-fluorophenyl)-1-(4-methoxyphenyl)ethan-1-one
• 英文别名: 2-bromo-2-(4-fluorophenyl)-1-(4-methoxyphenyl)ethanone
• CAS: 951744-04-0
• 化学式: C₁₅H₁₂BrFO₂
• 分子量: 323.161
• InChiKey: PSKIIVKIIBEIHC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-bromo-2-(4-fluorophenyl)-1-(4-methoxyphenyl)ethan-1-one 在 三乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 12.5h， 生成 4-(5-(4-Fluorophenyl)-4-(4-methoxyphenyl)thiazol-2-yl)-1-(N-hydroxy-N-methylcarbamoyl)-piperidine
  参考文献：
  名称：

  EP2009006

  摘要：

  公开号：
• 作为产物：
  描述：

  2-(4-Fluorophenyl)-1-(4-methoxyphenyl)ethan-1-one 在 copper(ll) bromide 作用下， 以 二氯甲烷 、 乙酸乙酯 为溶剂， 反应 18.0h， 以86%的产率得到2-bromo-2-(4-fluorophenyl)-1-(4-methoxyphenyl)ethan-1-one
  参考文献：
  名称：

  BF 3 ·OEt 2介导的[1,2]-芳基转移：通过取代的脱氧安息香的溴化/氰化/去甲酰基化合成官能化的α-芳基腈

  摘要：

  通过取代的脱氧安息香素的溴化/氰化/去甲酰基化，开发了一种新的顺序串联的官能化α-芳基腈的合成方法。CuBr 2促进的取代脱氧安息香素的溴化反应生成2-溴-2-芳基乙酰基3。的氰化3用氰化钠（NaCN的）epoxynitrile生成。然后，用BF 3 · OEt 2处理环氧腈导致通过1,2-芳基转移形成官能化的α-芳基腈4。

  DOI：

  10.1016/j.tet.2017.07.015

文献信息

• UREIDE DERIVATIVE AND PHARMACEUTICAL APPLICATION THEREOF
  申请人：Sugawara Yuji

  公开号：US20100234395A1

  公开（公告）日：2010-09-16

  Discloses is a pharmaceutical agent comprising an ureide derivative represented by the formula: or a pharmaceutically acceptable salt thereof as an active ingredient. The ureide derivative or the pharmaceutically acceptable salt thereof is useful for the relief of a pain or the treatment or prevention of neurogenic pain.

  Discloses是一种药物代理剂，包括一种由以下公式表示的尿素衍生物或其药学上可接受的盐作为活性成分。该尿素衍生物或其药学上可接受的盐对缓解疼痛或治疗或预防神经源性疼痛有用。
• UREIDE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES
  申请人：TORAY INDUSTRIES, INC.

  公开号：EP2009006A1

  公开（公告）日：2008-12-31

  This invention relates to a pharmaceutical comprising, as an active ingredient, a ureide derivative represented by formula: or a pharmaceutically acceptable salt thereof. The ureide derivative or a pharmaceutically acceptable salt thereof according to the present invention is useful for relieving pain and treating or preventing neuropathic pain.

  本发明涉及一种药物，其活性成分包括由式表示的脲衍生物： 或其药学上可接受的盐。根据本发明的脲苷衍生物或其药学上可接受的盐可用于缓解疼痛、治疗或预防神经性疼痛。
• Synthesis, cytotoxic evaluation, and molecular docking study of 4,5-diaryl-thiazole-2-thione analogs of combretastatin A-4 as microtubule-binding agents
  作者：Marjan Salehi、Seyed Nasser Ostad、Gholam Hossein Riazi、Amir Assadieskandar、Tayebeh Cheraghi-Shavi、Abbas Shafiee、Mohsen Amini

  DOI：10.1007/s00044-013-0754-6

  日期：2014.3

  A series of combretastatin A-4 analogs in which cis-olefinic bond replaced by thiazole ring were prepared by reaction of alpha-bromo-1,2-(p-substituted)diaryl-1-ethanones and dithiocarbamate derivatives. The cytotoxicity of these compounds was determined against three cancer cell lines (HT-29), (MCF-7), (AGS) as well as fibroblastic cell line (NIH-3T3) using MTT assay. Inhibition of tubulin polymerization for some potent compounds was evaluated. These biological studies proved that 6j and 6o were the most potent compounds in this series. Furthermore 2-(methylthio)-substituted compounds show moderate or no activity. Docking studies involving 6j and 6o demonstrated that this analogs could be successfully docked in the colchicine binding site of alpha,beta-tubulin.
• Convenient and Regiospecific Method for Synthesis of 4,5-Diaryl-1-methyl-2-(methylthio)-1<i>H</i>-imidazole
  作者：Amir Assadieskandar、Marjan Salehi、Mohsen Vosooghi、Abbas Shafiee、Mohsen Amini

  DOI：10.1080/00397911.2012.717670

  日期：2013.9.17

  A convenient, high-yielding, regiospecific synthesis of 1H-imidazole-2-thiones ring has been developed. In addition, a series of 4,5-diaryl-1-methyl-2-(methylthio)-1H-imidazoles 8 were synthesized and characterized. The structure of regioisomers was confirmed through nuclear Overhauser effect spectroscopy and NMR spectroscopy. Supplemental materials are available for this article. Go to the publisher's online edition of Synthetic Communications (R) to view the free supplemental file.
• 5,6-Diaryl-2,3-dihydroimidazo[2,1-b]thiazoles: a new class of immunoregulatory antiinflammatory agents
  作者：Paul E. Bender、David Hill、Priscilla H. Offen、Kazys Razgaitis、Patricia Lavanchy、Orum D. Stringer、Blaine M. Sutton、Don E. Griswold、Michael DiMartino

  DOI：10.1021/jm00147a008

  日期：1985.9

  A series of substituted 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles were synthesized and evaluated in the rat adjuvant-induced arthritis and mouse oxazolone-induced contact sensitivity assays to determine the potential of these compounds for use as immunoregulatory antiinflammatory agents. This class of compounds was derived by combining salient structural features of the antiinflammatory agent flumizole and the immunoregulatory drug levamisole. Unlike the latter two, a number of compounds in the target series were found to possess the desired combination of activities. Exploration of structure-activity relationships in the adjuvant-induced arthritic rat assay revealed that optimal potency was exhibited by symmetrically substituted 5,6-diaryl compounds having one of the following alkyl heteroatom or halogen functions at the para position: methoxy, ethoxy, methylthio, N-ethyl-N-methylamino, fluoro, or chloro. Scrambling of these two substituent classes to yield the asymmetrically substituted 5,6-diaryl compounds resulted in potent activity only with the 5-alkyl heteroatom, 6-halo-substituted regioisomers. However in the oxazolone-induced contact sensitivity assay, no consistent relationship of variation in activity with structural change was apparent. The initial target compound 5,6-bis(4-methoxyphenyl)-2,3-dihydroimidazo[2,1-b]thiazole (1) was compared with its progenitors in additional models of inflammation and immunoregulation.